Rhuzdah Kit
Product Images NDC 59651-740

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rhuzdah (NDC 59651-740). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Norethindroneethinyl Fig1)

The text consists of a figure that shows Circulatory Disease Mortality Rates per 100,000 Women-Years categorized by Age, Smoking Status, and Oral Contraceptive Use. The figure presents Mortality Rates for Ever-Users (Non-Smokers & Smokers) and Controls (Non-Smokers & Smokers) across four age groups (15-24, 25-34, 35-44, and 45+). The Mortality Rates range from 0 to 250, and the figure suggests that age, smoking status, and oral contraceptive use are correlated with varying Mortality Rates.*

FDA Label Image

Figure (Norethindroneethinyl Fig2)

This text presents information on various studies related to the use of contraceptives among women. The studies include NICHD Women's Contraceptive Study, French E3N cohort Study, Shanghai Women's Health Study, The Nurses' Health Study II, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study. The text provides estimates of effect (OR/RR) for ever use and current use of contraceptives in these studies. The information is presented in a tabular format that includes numeric values and corresponding study names and years.*

FDA Label Image

Figure (Norethindroneethinyl Fig3)

FDA Label Image

Package Label-principal Display Panel -0.4 mg/0.035 mg (28 Tablets Pouch) (Norethindroneethinyl Fig4)

FDA Label Image

Package Label-principal Display Panel -0.4 mg/0.035 mg (6 X 28 Tablets) (Norethindroneethinyl Fig5)

This is a description for oral contraceptive pills with 0.4 mg/0.035 mg strength of norethindrone and ethinyl estradiol tablets, USP. The package contains 6 pouches, and each pouch has 28 tablets. These pills are taken once a day as per the prescription to prevent pregnancy. However, they do not protect against sexually transmitted diseases or HIV/AIDS. Dosage and other information are provided on the package. Please keep the package in a controlled room temperature and out of the reach of children.*

FDA Label Image

Chemical Structure (Norethindroneethinyl Str)

This text provides chemical information about two compounds - Norethindrone Ethinyl Estradiol. It includes their molecular formulas and weight. The first line shows the chemical structure of an unknown compound with the formula C=CH.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.